PDLI

PDL BioPharma, Inc.
PDLI

Overview Fund Activity
Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

204 hedge funds and large institutions have $946M invested in PDL BioPharma, Inc. in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 77 increasing their positions, 73 reducing their positions, and 27 closing their positions.

Holders
204
Holders Change
-11
Holders Change %
-5.12%
% of All Funds
5.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
77
Reduced
73
Closed
27
Calls
$7M
Puts
$1.4M
Net Calls
+$5.6M
Net Calls Change
+$3.06M

Top Buyers

1
GAM
1
Gotham Asset Management
New York
$46.5M
2
First Trust Advisors
2
First Trust Advisors
Illinois
$113M
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$18.9M
4
GC
4
Guggenheim Capital
Illinois
$16.1M
5
AL
5
AJO LP
Pennsylvania
$17.1M

Top Sellers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$30.1M
2
Morgan Stanley
2
Morgan Stanley
New York
$4.24M
3
Allianz Asset Management
3
Allianz Asset Management
Germany
$4.32M
4
Citadel Advisors
4
Citadel Advisors
Florida
$14K
5
HCM
5
Highbridge Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
FHA
226
First Horizon Advisors
Tennessee
– – -186 Closed
TRCT
227
Tower Research Capital (TRC)
New York
– – -99 Closed
SEI Investments
228
SEI Investments
Pennsylvania
$0 83 -58 -41%
WCM
229
Wealthcare Capital Management
Virginia
– – -12 Closed
WT
230
Whittier Trust
California
$0 20 – –
O
231
OrbiMed
New York
– – – –
W
232
Wealthfront
California
$0 76 +65 +591%
6 7 8 9
10